Asensus Surgical Inc
F:2TX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shanghai Zhida Technology Development Co Ltd
HKEX:2650
|
CN |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (12.9), the stock would be worth €-3.42 (1 241% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -1.1 | €0.3 |
0%
|
| Industry Average | 12.9 | €-3.42 |
-1 241%
|
| Country Average | 14.4 | €-3.81 |
-1 371%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Asensus Surgical Inc
F:2TX
|
81.6m EUR | -1.1 | -1.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
168.1B USD | 14.6 | 26.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.6B USD | 44.2 | 58.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
131.3B USD | 20.6 | 40.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.6B USD | 13.3 | 24 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
95.3B USD | 19.5 | 32.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.9B EUR | 11.6 | 20.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47B USD | 23.9 | 43.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
47B USD | 31.3 | 44.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.1B USD | 10.1 | 25.7 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
34B USD | 11.7 | 16.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10 |
| Median | 14.4 |
| 70th Percentile | 21.5 |
| Max | 1 767 274.1 |
Other Multiples
Asensus Surgical Inc
Glance View
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. The company is headquartered in Durham, North Carolina and currently employs 183 full-time employees. The firm is engaged in digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery (PGS), by unlocking clinical intelligence to enable surgeons to deliver consistently superior outcomes to patients and establish a new standard of surgery. The firm is focused on the market development for and commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance System is a digital, multi-port laparoscopic platform designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation including 3 millimeters (mm) micro-laparoscopic instruments, 5mm articulating instruments, eye-sensing camera control and fully-reusable standard instruments to help maintain per-procedure costs similar to traditional laparoscopy.
